Innovotech Inc. (TSXV: IOT), a Canadian contract research organization specializing in biofilm science and antimicrobial testing, announced its intention to apply for a stock quotation on the OTCQB Venture Market, an over-the-counter market in the United States. The move aims to enhance the company's visibility among the investment community and make its shares more accessible to retail and institutional investors in the U.S., ultimately increasing liquidity.
The OTCQB quotation will operate in parallel with Innovotech's primary listing on the TSX Venture Exchange. According to the company, the OTCQB listing is not expected to impose additional material compliance or reporting requirements. As a foreign private issuer, Innovotech will continue to meet its existing disclosure obligations on SEDAR+, which satisfy OTC market requirements under established foreign issuer exemptions. To qualify for the OTCQB, companies must meet certain financial standards, be current in their reporting, and undergo an annual verification and management certification process.
In conjunction with the OTCQB application, Innovotech will also seek eligibility with the Depository Trust Company (DTC). DTC eligibility would enable simplified electronic clearing and settlement of its common shares for U.S. investors, further streamlining the trading process.
Innovotech is a boutique contract research organization that provides advanced laboratory services and commercializes proprietary technologies. The company is a leader in biofilm science, offering expertise in antimicrobial testing, pharmaceutical analysis, and industrial laboratory solutions. Its widely-used MBEC Assay® kit facilitates high-throughput antimicrobial and antibiotic testing. Innovotech serves clients across multiple sectors, delivering customized research and testing services designed to meet rigorous regulatory and scientific standards, such as those of the U.S. Food and Drug Administration and Health Canada, through its ISO-certified and GMP-accredited laboratories.
The company's decision to pursue a U.S. listing reflects a strategic effort to broaden its investor base and improve market access. By increasing its presence in the U.S. capital markets, Innovotech aims to attract additional investment to support its growth initiatives. The OTCQB is a venture market designed for early-stage and developing companies, providing a platform for increased transparency and liquidity.
Forward-looking statements in the announcement highlight potential risks and uncertainties, including regulatory outcomes, currency fluctuations, reliance on a small number of customers, and intellectual property protection. Innovotech undertakes no obligation to update forward-looking statements except as required by law.
For more information about Innovotech's services and technologies, visit https://www.innovotech.ca. The original press release is available at https://www.newmediawire.com.
